#hgco19

HGCO19 Gennova Vaccine: India’s first indigenous mRNA COVID-19 vaccine candidate gets nod for human trial

The mRNA vaccines do not use the conventional model to produce immune response India’s first indigenous mRNA vaccine candidate has received approval from the drug regulators to start Phase I/II human clinical trial. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, Pune and supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of M/o Science &…